IM Cannabis Corp. (IMCC) stock
IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.55−0.02 (-3.83%)
Close on Nov 12, 2026Market cap $3.26MP/E –Yield –
IM Cannabis EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2024 it was -4.51 CAD. The highest annual figure on record is -4.45 CAD in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -4.51 CAD | – |
| FY2023 | Dec 31, 2023 | -4.45 CAD | – |
| FY2022 | Dec 31, 2022 | -161.88 CAD | – |
| FY2021 | Dec 31, 2021 | -40.20 CAD | – |
| FY2020 | Dec 31, 2020 | -11.40 CAD | – |
| FY2019 | Dec 31, 2019 | -13.80 CAD | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -0.47 CAD | – |
| Q2 FY2025 | Jun 30, 2025 | -0.09 CAD | – |
| Q2 FY2024 | Jun 30, 2024 | -1.36 CAD | – |
| Q2 FY2023 | Jun 30, 2023 | -1.56 CAD | – |
| Q2 FY2022 | Jun 30, 2022 | -18.72 CAD | – |
| Q2 FY2021 | Jun 30, 2021 | -13.80 CAD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?